31502 Federal Register / Vol. 63, No. 110 /Tuesday, June 9, 1998 / Notices

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Administration for Children and

Families

[Program Announcement No. ACF/ACYF/

CB–98–04]

Fiscal Year (FY) 1998 Notice of an

Announcement of the Availability of

Financial Assistance and Request for

Applications To Support

Demonstration Projects Under the

Adoption Opportunities Program

AGENCY: Administration on Children,

Youth and Families, ACYF, ACF,

DHHS.

ACTION: Notice of Fiscal Year (FY) 1998

availability of financial assistance and

request for applications to support

demonstration projects under the

Adoption Opportunities Program, Title

II of the Child Abuse Prevention and

Treatment Act, as amended, Pub. L.

104–235.

SUMMARY: The Children’s Bureau,

within the Administration on Children,

Youth and Families announces the

availability of FY 1998 funds for

competing new discretionary grants

under the Adoption Opportunities

Program. Adoption Opportunities

Program funds are designed to provide

services that facilitate the elimination of

barriers to adoption and to provide

permanent loving homes for children

who would benefit from adoption,

particularly children with special needs.

Specific priority areas for which grant

awards are being solicited include:

98.1—National Resource Center on

Special Needs Adoption

98.2—Administration of the Interstate

Compact on Adoption and Medical

Assistance

98.3—Achieving Increased Adoptive

Placements of Children in Foster Care

98.4—Effective Collaborations for

Timely Adoptions

98.5—Overcoming State and Local

Barriers to Adoption

98.6—Adoption 2002 Support Project

98.7—Post-Legal Adoption Services

DATES: The date and time deadline for

RECEIPT of applications by DHHS for

new grants under this announcement

4:30 p.m. (Eastern Time Zone) on July

24, 1998.

FOR FURTHER INFORMATION CONTACT:

Copies of the program announcement

will be automatically sent to all current

Adoption Opportunities Program

grantees, all organizations that applied

for grant awards in FY 97 and all

individuals and organizations that have

asked to be placed on the mailing list for

FY 1998. Copies of the program

announcement can be obtained the

ACYF Operations Center at 1–800–351–

2293. A copy of this program

announcement is also located at the CB

website at http://www.acf.dhhs.gov/

programs/CB under Policy and Funding

Announcements.

SUPPLEMENTARY INFORMATION: Grant

awards of FY 1998 funds will be made

by September 30, 1998. The estimated

funds available for new awards is $4.9

million and the approximate number of

new grants is estimated at 28.

(Catalog of Federal Domestic Assistance.

Number 93.652, Adoption Opportunities

Grants)

Dated: June 3, 1998.

James A. Harrell,

Deputy Commissioner, Administration on

Children, Youth and Families.

[FR Doc. 98–15284 Filed 6–8–98; 8:45 am]

BILLING CODE 4184–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

[Docket No. 98N–0373]

Agency Information Collection

Activities: Proposed Collection;

Comment Request

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing an

opportunity for public comment on the

proposed collection of certain

information by the agency. Under the

Paperwork Reduction Act of 1995 (the

PRA), Federal agencies are required to

publish notice in the Federal Register

concerning each proposed collection of

information, including each proposed

extension of an existing collection of

information, and to allow 60 days for

public comment in response to the

notice. This notice solicits comments on

FDA Recall Regulations under 21 CFR

part 7. Recall guidelines set forth

procedures to be used by manufacturers

and distributors or other responsible

persons in notifying or alerting health

professionals or other persons of an

unreasonable risk of substantial harm to

the public’s health and describe the

procedures used or required by FDA in

the recall process.

DATES: Submit written comments on the

collection of information by August 10,

1998.

ADDRESSES: Submit written comments

on the collection of information to the

Dockets Management Branch (HFA–

305), Food and Drug Administration,

12420 Parklawn Dr., rm. 1–23,

Rockville, MD 20857. All comments

should be identified with the docket

number found in brackets in the

heading of this document.

FOR FURTHER INFORMATION CONTACT:

JonnaLynn P. Capezzuto, Office of

Information Resources Management

(HFA–250), Food and Drug

Administration, 5600 Fishers Lane,

Rockville, MD 20857, 301–827–4659.

SUPPLEMENTARY INFORMATION: Under the

PRA (44 U.S.C. 3501–3520), Federal

agencies must obtain approval from the

Office of Management and Budget

(OMB) for each collection of

information they conduct or sponsor.

‘‘Collection of information’’ is defined

in 44 U.S.C. 3502(3) and 5 CFR

1320.3(c) and includes agency requests

or requirements that members of the

public submit reports, keep records, or

provide information to a third party.

Section 3506(c)(2)(A) of the PRA (44

U.S.C. 3506(c)(2)(A)) requires Federal

agencies to provide a 60-day notice in

the Federal Register concerning each

proposed collection of information,

including each proposed extension of an

existing collection of information,

before submitting the collection to OMB

for approval. To comply with this

requirement, FDA is publishing notice

of the proposed collection of

information listed below.

With respect to the following

collection of information, FDA invites

comments on: (1) Whether the proposed

collection of information is necessary

for the proper performance of FDA’s

functions, including whether the

information will have practical utility;

(2) the accuracy of FDA’s estimate of the

burden of the proposed collection of

information, including the validity of

the methodology and assumptions used;

(3) ways to enhance the quality, utility,

and clarity of the information to be

collected; and (4) ways to minimize the

burden of the collection of information

on respondents, including through the

use of automated collection techniques,

when appropriate, and other forms of

information technology.

FDA Recall Regulations—Part 7 (21

CFR Part 7), Subpart C—(OMB Control

Number 0910–0249—Extension)

These regulations were established to

provide guidance to manufacturers on

recall responsibilities. These

responsibilities include development of

a recall strategy; providing complete

details of the recall reason, risk

evaluation, quantity produced,

distribution information, firm’s recall